Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CZNI take out the 5's watch it fly.
$AGYP Current RSI = 39
https://schrts.co/HrcDnWxW
$AGYP Reuters Article on the recent spike in Oil prices: Oil rises on U.S. crude stocks data, tight supply outlook
https://www.reuters.com/business/energy/oil-prices-ease-russia-output-increases-2022-08-18/
$BLEG Low Float 32,812,139 08/12/2022
All verified by the Transfer Agent
Authorized Shares 900,000,000 08/12/2022
Outstanding Shares 296,982,816 08/12/2022
(company cancelled another 60 million per its PR)
I/O will be 236,982,816
Held at DTC 32,812,139 08/12/2022 <technically what's in the float
Float 49,897,887 12/20/2021 <--This hasn't changed in a year
STRH should see something more on this soon with a 6.5M float https://finance.yahoo.com/news/star8-corp-signs-binding-letter-120000594.html
$HTSC announced operating income of $1,320,883 for the nine months ended June 30, 2022, an increase of $952,164, or 258%, as compared to operating income of $304,750, for the nine months ended June 30, 2021.
Revenues increased 145% to $1,935,374 for the nine months ended June 30, 2022, as compared to $790,800 for the nine months ended June 30, 2021.
"We continue to generate operating profits from our ICF Industries subsidiary as we explore for nickel and gold," said Paul Riss, CEO. "We are in negotiations to bring a drill to our Gowan project in September, to drill a core hole that contained 27 feet of 3.5% nickel sulfide and 1.2% copper in a near surface intercept."
The Company has exploration drilling permits for its projects located in the Beck, Ottaway, Lennox and Gowan townships in the renowned Timmins Mining Camp of Ontario. The Company controls approximately 9,000 acres of prospective properties.
"We also believe we will have liquidity in our investment portfolio in the next quarter, that will generate cash for an additional drill program," continued Riss. "Our investment portfolio consists of small-cap stocks and has decreased substantially in market value this year, but we are working with one issuer in our portfolio that anticipates a significant liquidity event this month that will allow us to deposit and sell its shares for our mining program."
The Company has uploaded its June 30, 2022 consolidated financial statements to OTC Markets. Please refer to the financial statements for complete details of the Company's third quarter fiscal 2022 operating results.
BDPT look at the float-Unrestricted 78,947,188
07/28/2022
MLFB Play of the Day!!! Still moving forward. Stock is Oversold and Major News today. This was over .03 this year.......will keep moving!!
$INKW PR: Greene Concepts Launches Happy Mellow Immune Support CBD Beverage!
PR: Greene Concepts (@GreeneConcepts) Launches Happy Mellow Immune Support CBD Beverage
— BevNET.com (@BevNET) August 17, 2022
Link: https://t.co/agsk7Ea9Dv pic.twitter.com/0hFlaAq6o7
$MLFB Stock is SO THIN Now.....the whole float might get traded today!!! Watch Out....Massive Runner!!
$PVSP SEATTLE, WASHINGTON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced that it continues to successfully restructure various aspects of its business and launched new contract supply arrangements for a major national brand.
https://finance.yahoo.com/news/restructuring-leading-500-000-annual-131500760.html
MLFB Exploding. Season for 2023 is coming. They are now Pink Current and just received 2.5m in funding. This is HUGE NEWS!!! Plus....the stock is WAY OVERSOLD!!
$INND InnerScope Hearing Technologies (OTC: INND) Announces FDA Has Released The Final Rule For OTC Hearing Aids
#smallcaps #microcaps @TradingView #pennystocks #stocktowatch #stocktobuy @Stocktwits #forextrading #traders
https://www.otcmarkets.com/stock/INND/news/InnerScope-Hearing-Technologies-OTC-INND-Announces-FDA-Has-Released-The-Final-Rule-For-OTC-Hearing-Aids?id=368994
$ZICX buy now and thank me later. When the imminent 300 million $ contract news hits the wires, u will thank me a 100 times.
$GTVH via InvestorWire -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) is proud to announce the advancement of its recent partnership with Electryone Advisors as the company has formally secured an exclusive “parent” representation agreement to market, sell and distribute the Electryone Advisors Carbon Credit Automation and Monetization Platform. This first to the U.S market platform automates the verification, issuance and monetization of carbon credits and can provide an immediate and additional revenue stream to any business that currently owns a system producing at least one megawatt-hour of “green” energy per day.
The platform meets the highest global standards and the credits issued adhere to the International Renewable Energy Credit Foundation’s protocols - the world's foremost regulatory body for Renewable Energy Credits. This allows the credits verified by the Electryone Platform to be sold worldwide on the open market at the highest value possible. Other key benefits include, but are not limited to:
Plug and play technology that directly connects to nearly any green energy system through an application program interface (API)
Approved by leading 3rd party Carbon Credit auditors across the world
Zero cost, risk or maintenance is required from project owners
Most profitable renewable energy program with a global network of traders
Accelerates clean energy adoption by providing access to carbon credit revenue
Client dashboard with real-time monitoring of credit production and sales for full transparency
ENDP...........EVFM............SNMP..........CYBN..........https://stockcharts.com/h-sc/ui?s=ENDP&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=EVFM&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=SNMP&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=CYBN&p=D&yr=0&mn=2&dy=12&id=p84071410134
$PVSP The Company’s board of directors has authorized a reduction of the number of authorized shares by 2 billion and will file the necessary certificates of amendment. “This is a significant step for us. We are continually looking for ways to combat any manipulation of our stock and increase value for our shareholders. We believe this reduction leaves enough shares in reserve for us to undertake any needed capital raising efforts, while also minimizing dilution among our shareholders,” said German Burtscher, Chief Executive Officer.
In addition, the Company has decided to announce that no reverse splits will be entertained for the next 5 years. The only exception would be a future uplisting to OTCQX.
“We are still planning to complete our audits and uplist to OTCQB as soon as possible,” continued Burtscher. “In the meantime, we will follow through on our operating plans, continue to restructure and generate value for our shareholders. Addressing shareholder concerns regarding potential reverse splits has been on our mind for a while. A 5-year horizon will cover all eventualities, including equity that will be seasoned over the next 2 years.”
$ftxp news nice call Trader53 $Dpls too last year
ELEK movement, low floater quick mover
GEGI beautiful break new 52 week highs and moving much easier here now
All of iQSTEL's subsidiaries of Telecom Division will be attending as Sponsors at www.wholesalecongress.com Madrid, Sept 21 & 22, working on to reach and surpass $90 million revenue forecast for 2022 and revenue forecast for 2023.
$PVSP Restructuring Leading to $500,000 in Annual Cost Savings Plus New Customer Contracts
https://www.globenewswire.com/news-release/2022/08/04/2492511/0/en/Restructuring-Leading-to-500-000-in-Annual-Cost-Savings-Plus-New-Customer-Contracts.html
$AGYP Crude and Brent Oil are up drastically on the day due to tight supply outlook! So far up 1.6% on the day!
https://tradingeconomics.com/commodity/crude-oil
$ZICX here comes da buyers. The 300 million $ contract news, that is due to be released THIS week. will send it sky-high.
$ZICX waiting for the official 300 million $ contract news. Then kaaabbboooommm
~$ALF 1.48, run to $2.65 at least $$$ https://stockcharts.com/c-sc/sc?s=ALF&p=D&yr=1&mn=1&dy=23&i=p10808176206&r=5333
https://schrts.co/mdVvgwmq
Nasdaq 16M O/S | 8.21M Float
https://www.getalfi.com
$PBIO Pressure BioSciences Announces Contract for October 2022 Launch of Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue
https://www.accesswire.com/712609/pressure-biosciences-announces-contract-for-october-2022-launch-of-breakthrough-hemp-derived-cbd-product-estimating-2-million-incremental-2023-revenue
$HNRC HNRC 2022 Update Letter To Shareholders
https://www.prnewswire.com/news-releases/hnrc-2022-update-letter-to-shareholders-301608505.html
$BIEL The future is now with Bioelectronics.
Drug free healing is the new wave of the future.
DRUG-FREE RecoveryRx- an affordable, simple to use, wearable device that treats pain. http://recoveryrx.co #painmanagement #chronicpainmanagement #chronicpainrelief #painrelief #neuromodulation #electroceuticals #fdacleared #clinicallyproven
Learn more & request samples of DRUG-FREE RecoveryRx- an affordable, simple to use, wearable device that treats pain. https://t.co/uk178fKpV1 #painmanagement #chronicpainmanagement #chronicpainrelief #painrelief #neuromodulation #electroceuticals #fdacleared #clinicallyproven pic.twitter.com/Gz1FJhrAz2
— BioElectronics Corporation (@BielCorp) August 16, 2022
KRTL Holding Group Inc Welcomes Dr. Malcolm A. Leissring as Chief Science Officer of KRTL Biotech, Inc.
Lakewood, CO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc., an international research, and development company, has appointed Dr. Malcolm A. Leissring as its founding Chief Science Officer. "I am honored to be a part of this vibrant team of experts with such complementary expertise. The future indeed looks very bright for us," said Dr. Leissring.
Dr. Leissring is an internationally recognized neuroscientist with expertise in the molecular pathogenesis of Alzheimer 's disease and diabetes, along with extensive expertise in drug discovery and drug development. He holds an A.B. degree from the UC Berkeley, an M.A. from San Francisco State University, and a Ph.D. from UC Irvine. He conducted his postdoctoral training at Harvard Medical School under the mentorship of Dr. Dennis Selkoe, who is widely considered to be one of the leading Alzheimer's disease researchers in the world.
Dr. Leissring has held faculty positions at Harvard Medical School, The Scripps Research Institute, and Mayo Clinic, and currently runs his laboratory within the Institute for Memory Impairments and Neurological Disorders at UC Irvine (UCI MIND). His academic achievements include the publication of more than 60 scientific publications in top-tier journals such as Nature, Neuron, and the Proceedings of the National Academy of sciences, and he has been awarded numerous grants from the National Institutes of Health, the Alzheimer's Association, the American Diabetes Association among others.
Dr. Leissring pioneered the development of the first potent and selective inhibitors of insulin-degrading enzyme, which have demonstrated utility for the treatment of diabetes (Maianti et al., Nature 2014) and wound healing (Suire et al., PLoS ONE 2018). Dr. Leissring has received awards from many prestigious organizations, including the Alzheimer’s Association, the American Diabetes Association, the Ellison Medical Foundation, and the American Federation for Aging Research.
About KRTL Holding Group, Inc.
We are a holding company interested in diversifying risk and accessing new markets. The Company operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp., with precision and excellence and continues to create and strengthen the KRTL reputation. This allows KRTL Holding Group, Inc. to capitalize on any range of investment opportunities. Our organization values collaboration and emphasizes a transparent work environment. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com
https://www.globenewswire.com/newsroom/ti?nf=ODYyMTI1OCM1MDk5ODU0IzIyNTAxODU=
https://ml.globenewswire.com/media/N2IwMDdmMGQtNzNjZi00MGUzLThiN2YtODdlNGE3ZjZmZTU0LTEyNjE3Mzg=/tiny/KRTL-Holding-Group.png
KRTL Holding Group, Inc.
Main 800-707-0586
info@krtlholding.com
Source: KRTL Holding Group
© 2022 GlobeNewswire, Inc.
$OCLN OriginClear Second Quarter Revenue Up 240% Over Last Year https://yhoo.it/3psruR5
APSI https://twitter.com/inc_apsi/status/1560242955675475968?s=20&t=WYsKzqevP4ccegfjqf3zPQ
APSI - Aqua Power Systems Inc (@inc_apsi)
Update: 1) Working on project that would qualify $APSI to get Shell Status removed in very near term (in addition to larger merger project) 2) Productive phone call yesterday on merger project. Now scheduling multi-party conf call to move ball up the field on project.
Twitter•Today at 8:31 AM
$HTSC Stock Quote https://www.otcmarkets.com/stock/HTSC/quote
$GTVH heading for a breakout soon: Golden Triangle Ventures is a publicly traded Company that holds an array of unique businesses, partnerships, projects and global business relationships that all provide a mutual and significant value added to the organization and its goals within. Our goal is to assemble a strong portfolio of successful businesses under one overarching umbrella. Our pioneering spirit and strategic vision will allow us to achieve success and deliver optimal results.
$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets
https://www.pervasip.net/zen-asset-management-zam
$ODYY NEWS OUT!!!
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
Las Vegas, NV, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announced the successful completion of safety measures for their Phase I Multi-Day Ascending Dosing (MAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For MAD Cohort I, the drug was safe and well tolerated.
Cohort I of the MAD trial was conducted at Nucleus Network, a leading clinical research organization. Cohort I findings were evaluated by the Safety Review Committee. Eight healthy human volunteers received one dose of PRV-002 or placebo for five consecutive days followed by evaluations for abnormal responses. No severe adverse events were noted as PRV-002 was well-tolerated. Vital signs, EKG readings and breathing function were all normal. Blood labs showed no alterations associated with multi-day PRV-002 treatment. Pharmacokinetic analysis showed a direct linear relationship between drug dosing concentration and blood plasma levels for each of the five days of dosing. There was no appreciable accumulation of the drug with consecutive day treatments. Blood levels of PRV-002 were significantly lower on average with intranasal administration than what would be expected with other routes of delivery.
“After reviewing the data from MAD Cohort I, I have strong confidence that PRV-002 will continue to show safety during the final, high dose MAD portion of the Phase I clinical trial. We have unanimously approved the start of MAD Cohort II. The overall low levels of PRV-002 in the blood support the hypothesis that more drug is getting to the brain itself when administered with the intranasal device. If this turns out to be the case not only can the targeted effects of the drug be more efficacious, but the drug will also likely have fewer potential side effects.” commented Dallas Hack, MD, member of the Safety Review Committee.
Philip Ryan, MD, Principal Investigator for Nucleus Network, commented, “Low dose PRV-002 was well-tolerated when given daily for five days. There was no drug accumulation in the blood and levels were much lower than the established toxicity levels seen in the animal studies. The Safety Review Committee has confidence about the safety of the intranasal delivery of PRV-002. We look forward to completing the final high dose MAD portion of the Phase I trial and assisting Odyssey with their Phase II/III design to determine the efficacy of PRV-002 for concussed patients.”
Odyssey is currently selecting clinical sites and developing the Phase II Investigator’s Brochure for the Phase II trial. Concussions represent an ‘unmet’ medical need and affect millions worldwide. A single concussion can significantly increase the risk of developing a mental health disorder in youth.
The global market for concussion treatment was valued at $6.9 billion in 2020 and is forecasted to reach $8.9 billion by 2027, according to Grandview Research. Common settings for concussion include contact sports, military training and operations, motor vehicle accidents, children at play and falls in elderly assistive-living facilities.
About Odyssey Health Inc. (formerly Odyssey Group International, Inc.)
Odyssey Health Inc. (OTC: ODYY) is a medical company with a focus in the area of life-saving medical solutions. Odyssey's corporate mission is to create, acquire and develop distinct assets, intellectual property, and exceptional technologies that provide meaningful medical solutions. The company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. For more information, visit the company’s website at www.odysseyhealthinc.com
We encourage our shareholders to visit our corporate social media accounts for updates:
https://twitter.com/OdysseyHealth1
https://www.facebook.com/odysseyhealthinc
https://www.linkedin.com/company/odysseyhealthinc
https://www.youtube.com/channel/UCsS--v0od_fYIBu2tvqmj9Q
About PRV-002
PRV-002 is a fully synthetic non-naturally occurring neurosteroid being developed for the treatment of mTBI (concussion). In preclinical studies, PRV-002 has demonstrated equivalent, if not superior, neuroprotective effects compared to related neurosteroids. Animal models of concussion demonstrated that PRV-002 reduces the behavioral pathology associated with brain injury symptoms such as memory impairment, anxiety, and motor/sensory performance. Additionally, PRV-002 is lipophilic and can easily cross the blood-brain barrier to rapidly eliminate swelling, oxidative stress and inflammation in the brain while restoring proper blood flow.
About Nucleus Network
Nucleus Network is the only multi-site Phase 1 clinical trials provider located in Australia and the USA. Nucleus Network provides high-quality, first-in-human and early-phase trials for biotechnology and pharmaceutical companies across the USA, Europe and Asia. Located within cutting-edge health precincts, their cost-effective, accelerated clinical development solutions are supported by advanced technology, clinical excellence, and research expertise.
Forward-Looking Statements
This news release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including our ability to continue to raise needed funds, successfully complete the Phase I trial, our ability to successfully develop products, rapid changes in our markets, changes in demand for our future products, and legislative, regulatory, competitive developments and general economic conditions.
Inquiries:
Odyssey Health
info@odysseyhealthinc.com
https://www.globenewswire.com/newsroom/ti?nf=ODYyMTI1MyM1MDk5OTY4IzUwMDA4NjI2NA==
https://ml.globenewswire.com/media/OTk4ZjE1MGEtMWFiYi00MjNhLWIyNmMtZTZjOTMyMTNhNWZiLTUwMDA4NjI2NA==/tiny/Odyssey-Health-Inc.png
Source: Odyssey Health, Inc
$HTSC ICF Industries Inc. is an international distribution, consulting and sales organization committed to finding revolutionary and visionary products to ensure reliable sales and maximize profits. ICF Industries does not limit itself to one industry or service, and instead monitors and anticipates market trends to achieve its goal of mass distributing an array of superior products.
$HTSC Check out the management https://www.heretoserve.tech/team
$HTSC The Company has uploaded its June 30, 2022 consolidated financial statements to OTC Markets. Please refer to the financial statements for complete details of the Company's third quarter fiscal 2022 operating results.
https://www.marketwatch.com/press-release/here-to-serve-holding-corp-reports-nine-month-operating-income-of-1320883-with-revenues-of-1935374-2022-08-15?mod=mw_quote_news_seemore
$CBDL CBD Life Sciences, Inc. (CBDL) Distributes NEW Infused Gummies Nationwide
https://www.accesswire.com/712572/cbd-life-sciences-inc-cbdl-distributes-new-infused-gummies-nationwide
SCOTTSDALE, AZ / ACCESSWIRE / August 18, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is taking an innovative approach by introducing a product that is infused with both Delta-8 & Delta-9.
LBC Bioscience Inc. is yet again dominating the competition by creating new products along with continuous experimenting, and this product is a huge step forward for overall growth of the company! The delicious Green Apple flavored product the company is introducing are Infused Gummies with 15MG of Delta-8 & 10MG of Delta-9 per gummy and will come in a 15-Count Jar. This specific product is ideal for easing the mind while having staying focused all at the same time! All products are carefully blended to ensure consistency along with Third Party Lab Testing for verification. This product will be available in store as of today with the LBC website to follow within the next couple of days.
President & CEO Lisa Nelson states, "We have been working diligently to experiment and create a new product to deliver to our consumers & beloved shareholders and we will continue to keep the public updated moving forward!"
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension, even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
Followers
|
8273
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2342610
|
Created
|
12/20/05
|
Type
|
Free
|
Moderator MOMO | |||
Assistants i_like_bb_stock Cube balamidas |
*** PURPOSE of the BOARD is to alert both penny and big board stocks which are breaking out in play.
Furthermore, this board provides an open forum for both experienced and new traders alike to shares their stock picks, opinions and experiences.
At one time or another, we were all new to trading and looking for a place to learn and understand the market, which is one of the main reasons this board was created.
This forum provides new investors a place to learn and feel comfortable doing it.
*** ALERTS are based on stocks that show an acceleration of price or volume; showing signs of reversing based on their chart and volume are not suitable for all investors.
Due to the increased volatility and high risk exposure when trading penny stocks, it is possible to lose your entire investment.
Taking profits, due diligence and preservation of your initial investment is key and must be taken into consideration.
All stocks mentioned are welcome herr and range from pennies to the big boards and everything in between.
Do your own due diligence before investing and never trade more than you can afford to lose.
Traders should plan their exits before they trade and take profits the way up.
We are here to help -- let us know if we can be of any assistance.
*** A MUST HAVE for TRADERS http://www.equityfeed.com/
IMPORTANT / USEFUL LINKS
SHO LIST: http://www.nasdaqtrader.com/aspx/regsho.aspx
BUYINS.NET: http://www.buyins.net/
POST S-8 PLAYS: http://www.investorshub.com/boards/board.asp?board_id=1605
TOXIC FILINGS: http://www.investorshub.com/boards/board.asp?board_id=4318
REVERSE SPLITS: http://www.investorshub.com/boards/board.asp?board_id=3017
DEATH DROP: http://www.investorshub.com/boards/board.asp?board_id=3341
PRESS RELEASES:http://home.businesswire.com/portal/site/home/index.jsp?front_door=true
1512g Filings - http://1512g.com/
American Stock Exchange - http://www.nyse.com/attachment/amex_landing.htm
Authorized Shares for Nevada and Other States - http://www.authorized-shares.com/
Barrons - http://online.barrons.com/public/main
BioHealth - http://www.biohealthinvestor.com/
BioMed - http://biomedreports.com/
BioSpace - http://www.biospace.com/
Bloomberg - http://www.bloomberg.com
Business News - http://www.bloomberg.com
Business News - http://www.reuters.com/finance/markets
Business News Portal - http://www.businesswire.com/portal/site/home/
BusinessWeek - http://www.businessweek.com/
Candlesticks - www.candlesticker.com/Default.asp
Chart Analysis - www.stockcharts.com/school/doku.php
Chart Video Lessons - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46647251
Charts - http://bigcharts.marketwatch.com/avatar.asp
Charts - http://chartpatterns.com/
Charts - http://stockcharts.com/
Charts - http://www.incrediblecharts.com/technical/candlesticks.htm
China Business News - http://www.chinadaily.com.cn/bizchina/index.html
China Business News - http://www.xinhuanet.com/english2010/business/index.htm
China Technology News - http://www.chinatechnews.com/
Clinical Trials - http://www.clinicaltrials.gov/
CNBC - http://www.cnbc.com
CNNMoney.com - http://www.money.cnn.com/
Corporate Bankruptcy - http://www.sec.gov/investor/pubs/bankrupt.htm
Corporate Records Search - http://www.coordinatedlegal.com/SecretaryOfState.html
Corporate Records Search - http://www.searchsystems.net/list.php?nid=398
CUSIP number - http://activequote.fidelity.com/mmnet/SymLookup.phtml
DD Amanda - http://ddamanda.com/Members/AmandaChartStart.php
DD Machine - http://www.ddmachine.com/
Deregistering - http://www.aaii.com/commentary/articles/200601_stockstrategies.cfm
Dividends - http://www.dividenddetective.com/
Document Research - http://www.10kwizard.com/main.php
Earnings - http://www.earningswhispers.com/calendar.asp
Education - http://www.investopedia.com/?viewed=1
Email Address Verifier - http://verify-email.org/
EYE ON THE FDA - http://www.eyeonfda.com/
FINRA Daily Short List - www.regsho.finra.org/regsho-Index.html
Floats - http://investorshub.advfn.com/boards/board.aspx?board_id=15223
Fool.com - http://www.fool.com
Forbes - http://www.forbes.com/home_usa
Form 4 Filings - http://www.secform4.com/index.php
Google News Business - http://news.google.com/?ned=us&topic=b
Google News Home - http://news.google.com/
Holiday Schedule for Stock Markets - http://www.allstocks.com/html/stock_markets_holidays.html
High Short Interest Stocks - http://www.highshortinterest.com/
Insider Buy & Sell Info - http://www.insidercow.com/latestFillings/buyByCompany
Investing Glossary - http://www.investorwords.com/
Investopedia - http://www.investopedia.com/?viewed=1
Investors Business Daily - http://www.investors.com
Investor Words - http://www.investorwords.com/
Knobias - http://www.knobias.com/individual/public/quote.htm
Level 2 Video Tutorial - http://stockhideout.com/images/flash/level.html
Low Float Stocks - http://www.lowfloat.com/
MarketWatch.com - http://www.marketwatch.com/
Message, Blog & Twitter Postings - http://www.thelion.com
MicrocapMarkets NASDAQ <$5 - http://www.microcapmarkets.com/data_main_nav.jsp?market=NASDAQ
MicrocapMarkets OTCBB - http://www.microcapmarkets.com/data_main_nav.jsp?market=OTCBB
Mining - http://www.miningmx.com/
MSN Money Central - http://www.moneycentral.msn.com/investor/home.asp
Multicollinearity - www.stockcharts.com/help/doku.php
Mutual Fund Facts About Individual Stocks - http://www.mffais.com/
Naked Shorting - www.businessjive.com/
NASDAQ Stock Market - http://www.nasdaq.com/
NASDAQ/NYSE/AMEX Stock Info - www.secfilings.com/
Natural Resources News & Commentary - http://www.resourceinvestor.com/Pages/default.aspx
New York Stock Exchange - http://www.nyse.com/home.html
OTCBB Daily List - http://www.otcbb.com/dailylist/
Patterns - http://thepatternsite.com/
Pinksheets Stock Info - www.otcmarkets.com/pink/index.jsp
Platform - http://www.quotetracker.com/
Precious Metals - http://www.kitco.com/
Press Releases - http://www.prnewswire.com/news-releases/
REG SHO List - www.regsho.com/tools/short_list.php
Regional Bank List - http://www.bullsector.com/regionalbanks.html
Reverse Phone & Address - http://www.whitepages.com/reverse-lookup
Reverse Mergers - http://www.gopublic.com/reversemerger.html
Reverse Merger Report - http://reversemerger.dealflowmedia.com
Reverse Splits - http://investorshub.advfn.com/boards/board.aspx?board_id=3017
Screener - http://clearstation.com
Screener - http://smallcapcenter.com
Searching Blogs, News, etc. - http://www.icerocket.com/
SEC - http://www.sec.gov
SEC Filings - http://www.edgar-online.com/
SEC Filings - http://www.sec.gov/edgar/searchedgar/companysearch.html
SEC Filings - http://www.secinfo.com
SEC Form Types and Definitions - http://learn.westlawbusiness.com/support/formtypes.html
Secretary of State Sites - All states: http://www.coordinatedlegal.com/SecretaryOfState.html
Seeking Alpha BioTech Stocks - http://www.seekingalpha.com/sector/biotech
Shell Stocks - http://www.shellstockreview.com
SHO Threshold List - http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
Short Stocks - http://shortsqueeze.com/
Stock Chart Patterns - www.trending123.com/patterns/index.html
Stock Promotions - www.stockpromoters.com
Stock Promotions - www.stockreads.com/
Stock Research - http://www.stockhouse.com
Stock Scanning - http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=1&x=15&y=18
Stock Scanning - http://clearstation.etrade.com/cgi-bin/events?Cmd=techev
Stock Scanning - http://markets.usatoday.com/custom/usatoday-com/screener/screener.asp
Stock Scanning - http://screen.yahoo.com/stocks.html
Stock Scanning - http://stockcharts.com/def/servlet/SC.scan
Stock Scanning - http://www.acmechart.com/
Stock Scanning - http://www.americanbulls.com/
Stock Scanning - http://www.barchart.com/
Stock Scanning - http://www.prophet.net/scans/index.jsp
Stock Scanning - http://www.smallcapcenter.com/tools_technicalSearch.asp?page=ANALYTICSSEARCH_IN.ASP
Stock Scanning - http://www.stockciphering.com/index.htm
Stock Scanning - http://www.stockfetcher.com/
Stock Scanning - http://www.stockscores.com/index.asp
Stock Scanning - http://www.stockworm.com/help/tours/stock-screener.html;jsessionid=aEg_MdzO2SH9
Stock Scanning - http://www2.barchart.com/
Technical Analysis - http://stockta.com/
Technical Indicators/Overlays - www.stockcharts.com/school/doku.php
TheStreet.Com - http://www.thestreet.com/
Trading Halts - http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
Trading Platform - www.equityfeed.com
Trading Stations - http://www.tradingcomputers.com/index.html
Transfer Agent Contact Information - http://investorshub.advfn.com/boards/board.aspx?board_id=10067
Transfer Agents in the United States - http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Translation Tool - http://www.verbatimsolutions.com/freetranslation.php
USAToday Business - http://markets.usatoday.com/custom/usatoday-com/html-markets.asp
Complete List of Transfer Agents in the United States:
http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Stock Market Holiday Schedule
http://www.allstocks.com/html/stock_markets_holidays.html
RULES OF THE BOARD~
*** NO PERSONAL ATTACKS or VULGARITY WILL BE TOLERATED!!!
DISCLAIMER:
Opinions expressed on this board are just opinions. We are not licensed brokers.
Trading strategies discussed on this board are often high risk and are not suitable everyone.
If you consistantly lose money in the market, you may wish to seek the advice of a licensed securities professional.
No one is responsible for your gains or losses in the market except YOU.
Following stocks, strategies discussed on this board, you may LOSE ALL YOUR MONEY.
Please weigh the strategies discussed here carefully against what you are willing to risk.
Please do due diligence before buying or selling ANY SECURITY in the open market; are no guarantees.
TRADE WELL & REMEMBER TO TAKE PROFITS on THE WAY UP!
GOOD LUCK!
*** FOLLOW OUR ALERTS ON TWITTER ***
http://twitter.com/#!/pennystockmomo
*** FOR EARLY ALERTS SIGN UP FOR THE BREAKOUT TRADERS E-MAIL LIST ***
http://investorshub.advfn.com/boards/chairmail_sub.asp?board_id=4929
Posts Today
|
0
|
Posts (Total)
|
2342610
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |